Team Europe Support Structure (TESS) for MAV+

The Team Europe Support Structure (TESS) for MAV+ is described by EU sources as a coordination and technical assistance mechanism designed to improve access to vaccines, medicines, and health technologies across Sub-Saharan Africa, operating under the broader Manufacturing and Access to Vaccines, Medicines and Health Products (MAV+) Team Europe Initiative. According to EU framing, the project is intended to strengthen coordination, monitoring, and communication among Team Europe partners rather than to directly finance infrastructure or procurement. It is listed as being in Phase 4 of 5, suggesting it has been active for some time, though no precise start or end dates are available in the public record. The evidentiary basis for any independent assessment of this project is extremely thin. No financial commitments or disbursements appear in the IATI Datastore for this specific mechanism, and there are no matching records in the EIB project database. The investment figure is not publicly disclosed. In the absence of IATI data, which represents one of the more reliable signals of actual financial activity rather than political intent, it is not possible to verify that meaningful funding has flowed to this initiative. This is a significant gap. It is possible that TESS for MAV+ is funded through aggregated Team Europe contributions that are recorded under parent programmes rather than as a discrete line item, but that cannot be confirmed from available evidence. None of the independent news sources retrieved directly reference TESS for MAV+ by name. The closest contextually relevant item is a WHO-EU joint announcement from October 2025 concerning a collaboration to advance digitised health systems in Sub-Saharan Africa. While this reflects broader EU-Africa health system engagement, it cannot be attributed specifically to TESS for MAV+ without further confirmation.